Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04261088
Other study ID # 999920059
Secondary ID 20-CC-N059
Status Active, not recruiting
Phase
First received
Last updated
Start date February 3, 2020
Est. completion date January 31, 2025

Study information

Verified date September 20, 2023
Source National Institutes of Health Clinical Center (CC)
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Background: Researchers want to learn more about how the Swiss model of assisted suicide works. To do this, they have interviewed 25 Swiss experts. The researchers will draw on research in the fields of ethics, law, and medicine to analyze the transcripts. Objective: To describe the practice of assisted suicide in Switzerland and to study how the policy is carried out, how the right-to-die societies work, and the ethical implications of the practice. Eligibility: Swiss experts in the field of assisted suicide Design: The study includes 25 interviews that have already been conducted. The participants were: - academics - doctors and others in medical care - a government official - representatives of right-to-die societies. Researchers will analyze the data using qualitative methods. Two researchers will develop a coding scheme and code the texts and analyze the data.


Description:

Switzerland is the only country in the world that enables assisted suicide by lay people, i.e., people who are not physicians. All other countries that have adopted aid-in-dying legislation require that a physician provides this assistance. This project probes the reasons for adopting this policy, and the advantages and the disadvantages of the Swiss model at the end of life. Are the Swiss aid-in-dying volunteers able to provide well-informed assistance to patients in need? Is the Swiss model one to be followed by other nations? The project will focus on the work of the Swiss aid-in-dying societies. The study draws on research in the fields of ethics, law and medicine. Its novelty lies in incorporating different methods of analysis, reflecting on the right to die with dignity within a liberal framework that aims to respect fundamental human rights.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 25
Est. completion date January 31, 2025
Est. primary completion date January 31, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility - INCLUSION/EXCLUSION: The study includes 25 interviews with Swiss experts that have been conducted. - Gender: Men 14, Women 11 - Backgrounds of interviewees: Academics 14, Physicians and other medical care 6, Right to die associations 4, Government official 1 - Race and ethnicity: All white Swiss. - Age range: Unknown, but all are adults. - No vulnerable populations.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States National Institutes of Health Clinical Center Bethesda Maryland

Sponsors (1)

Lead Sponsor Collaborator
National Institutes of Health Clinical Center (CC)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Descriptive study This is a qualitative descriptive study of transcripts. Ongoing
See also
  Status Clinical Trial Phase
Completed NCT02845817 - Requests for Euthanasia and Assisted Suicide N/A
Completed NCT03353870 - Requests for Euthanasia and Assisted Suicide in Establishment of Accommodation for Dependent Old Persons.